Dr. Rauschenbach is an outstanding member of the Rutgers community and is recognized for her exceptional contributions to teaching and curriculum development
An early treatment for COVID-19 - created by researcher Liping Zhao - was given the Investigational New Drug status by the Food and Drug Administration